Drug Shortage Report for TENORMIN
Report ID | 201887 |
Drug Identification Number | 02039532 |
Brand name | TENORMIN |
Common or Proper name | TENORMIN |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ATENOLOL |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 tabs |
ATC code | C07AB |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2023-07-01 |
Actual start date | 2023-07-15 |
Estimated end date | 2024-02-28 |
Actual end date | 2024-01-31 |
Shortage status | Resolved |
Updated date | 2024-02-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-02-01 | English | Compare |
v8 | 2024-01-31 | French | Compare |
v7 | 2024-01-31 | English | Compare |
v6 | 2024-01-31 | English | Compare |
v5 | 2024-01-22 | English | Compare |
v4 | 2024-01-22 | French | Compare |
v3 | 2024-01-22 | English | Compare |
v2 | 2023-08-15 | French | Compare |
v1 | 2023-08-15 | English | Compare |
Showing 1 to 9 of 9